Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Berlanga · SciRah

Researcher profile · Semantic Scholar

P. Berlanga

Share profile

P. Berlanga — researcher profile on SciRah

h-index: 16
Works: 77
Citations: 904

Most-cited papers

The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies
P. Berlanga, G. Pierron, L. Lacroix, Mathieu Chicard +25 more
2022Cancer Discovery148 citations Open access
Semantic Scholar
Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: Standard of Care and Treatment Recommendations from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)
A. Ferrari, B. Brennan, M. Casanova, N. Corradini +11 more
2022Cancer Management and Research66 citations Open access
Semantic Scholar
Longitudinally Extensive Myelitis Associated With Immune Checkpoint Inhibitors
A. Picca, G. Berzero, K. Bihan, Vincent Jachiet +15 more
2021Neurology: Neuroimmunology & Neuroinflammation56 citations Open access
Semantic Scholar
Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG).
A. Ferrari, M. V. van Noesel, B. Brennan, I. Zanetti +13 more
2021The Lancet Child & Adolescent Health55 citations Open access
Semantic Scholar
Emerging therapies in Ewing sarcoma
Sandra J. Strauss, P. Berlanga, Martin G. McCabe
2024Current Opinion in Oncology34 citations Open access
Semantic Scholar
Chemo-immunotherapy with dinutuximab beta in patients with relapsed/progressive high-risk neuroblastoma: does chemotherapy backbone matter?
Patricia Raiser, G. Schleiermacher, M. Gambart, B. Dumont +21 more
2024European Journal of Cancer34 citations Open access
Semantic Scholar
Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer.
L. Moreno, M. Casanova, J. Chisholm, P. Berlanga +19 more
2018European Journal of Cancer33 citations Open access
Semantic Scholar
First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trial.
R. Morscher, C. Brard, P. Berlanga, L. Marshall +13 more
2021European Journal of Cancer32 citations Open access
Semantic Scholar
A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors
Maria Eugénia Marques da Costa, Sakina Zaidi, J. Scoazec, Robin Droit +32 more
2023Communications Biology30 citations Open access
Semantic Scholar
Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience.
P. Berlanga, C. Pasqualini, U. Pötschger, C. Sangüesa +19 more
2020European Journal of Cancer27 citations Open access
Semantic Scholar
Desmoplastic small round cell tumor: from state of the art to future clinical prospects
S. Hovsepyan, C. Giani, S. Pasquali, A. Di Giannatale +10 more
2023Expert Review of Anticancer Therapy25 citations Open access
Semantic Scholar
Measuring Safety and Outcomes for the Use of Compassionate and Off-Label Therapies for Children, Adolescents, and Young Adults With Cancer in the SACHA-France Study
P. Berlanga, L. A. Ndounga-Diakou, I. Aerts, N. Corradini +37 more
2023JAMA Network Open23 citations Open access
Semantic Scholar
Recent advances in understanding osteosarcoma and emerging therapies
N. Gaspar, Maria Eugénia Marques da Costa, O. Fromigué, Robin Droit +2 more
2020Faculty Reviews23 citations Open access
Semantic Scholar
Clinical characteristics and outcomes for children, adolescents and young adults with “CIC‐fused” or “BCOR‐rearranged” soft tissue sarcomas: A multi‐institutional European retrospective analysis
M. Sparber-Sauer, N. Corradini, M. Affinita, G. M. Milano +10 more
2023Cancer Medicine20 citations Open access
Semantic Scholar
Systematic review of phase‐I/II trials enrolling refractory and recurrent Ewing sarcoma: Actual knowledge and future directions to optimize the research
A. Félix, P. Berlanga, M. Toulmonde, J. Landman-Parker +4 more
2021Cancer Medicine20 citations Open access
Semantic Scholar
Clinical and molecular analysis of smoothened inhibitors in Sonic Hedgehog medulloblastoma
V. Pereira, Jacob Torrejon, D. Kariyawasam, P. Berlanga +13 more
2021Neuro-Oncology Advances17 citations Open access
Semantic Scholar
Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving ALK-Targeted Therapy
Charles Bobin, Y. Iddir, Charlotte Butterworth, J. Masliah-Planchon +30 more
2024Clinical Cancer Research16 citations Open access
Semantic Scholar
AcSé-ESMART, a European precision cancer medicine proof-of-concept platform trial
B. Geoerger, Xavier Paoletti, Francisco Bautista, S. Gatz +18 more
2023Nature Medicine16 citations Open access
Semantic Scholar
Management of sarcomas in children, adolescents and adults: Interactions in two different age groups under the umbrellas of GSF-GETO and SFCE, with the support of the NETSARC+ network.
E. Bompas, V. Martin, Fatima Meniai, M. Toulmonde +15 more
2021Bulletin du Cancer16 citations Open access
Semantic Scholar
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy Forum
S. Dubois, Lucas Moreno, John Anderson, S. Asgharzadeh +41 more
2025Pediatric Blood & Cancer14 citations Open access
Semantic Scholar
Li–Fraumeni‐associated osteosarcomas: The French experience
Emilie Saucier, G. Bougeard, A. Gomez-Mascard, C. Schramm +20 more
2024Pediatric Blood & Cancer12 citations Open access
Semantic Scholar
From biology to personalized medicine: recent knowledge in Osteosarcoma.
A. Mohr, Maria Eugénia Marques da Costa, Olivia Fromigue, B. Audinot +8 more
2024European Journal of Medical Genetics12 citations Open access
Semantic Scholar
Enasidenib treatment in two individuals with D-2-hydroxyglutaric aciduria carrying a germline IDH2 mutation
B. Geoerger, M. Schiff, V. Penard-Lacronique, N. Darin +12 more
2023Nature Medicine12 citations
Semantic Scholar
Precision cancer medicine platform trials: Concepts and design of AcSé-ESMART.
B. Geoerger, Francisco Bautista, Nicolas André, P. Berlanga +16 more
2024European Journal of Cancer11 citations
Semantic Scholar
Metastatic adult‐type non‐rhabdomyosarcoma soft tissue sarcomas in children and adolescents: A cohort study from the European paediatric Soft tissue sarcoma Study Group
A. Ferrari, D. Orbach, M. Casanova, M. V. van Noesel +16 more
2023Cancer11 citations Open access
Semantic Scholar
Recurrent and Refractory Ewing Sarcoma Phase I/II Trials: Current Perspective From the Euro-Ewing Consortium.
A. Juan-Ribelles, A. Félix, N. Benavent, Josep Escrivá-Fernández +11 more
2025JCO Precision Oncology10 citations Open access
Semantic Scholar
A randomised phase IIb trial of BEvACizumab added to Temozolomide ± IrinOtecan for children with refractory/relapsed Neuroblastoma - BEACON-Neuroblastoma, a European Innovative Therapies for Children with Cancer (ITCC) - International Society of Paediatric Oncology Europe Neuroblastoma Group (SIOPEN
L. Moreno, Jennifer Laidler, Veronica Moroz, C. Owens +16 more
201510 citations
Semantic Scholar
Current treatment strategies for first relapse of high-risk neuroblastoma.
Sveva Castelli, F. Schulze, T. Thole-Kliesch, K. Astrahantseff +25 more
2026European Journal of Cancer8 citations Open access
Semantic Scholar
Treatment at Relapse for Synovial Sarcoma of Children, Adolescents and Young Adults: From the State of Art to Future Clinical Perspectives
Andrea Ferrari, P. Berlanga, S. Gatz, R. Schoot +12 more
2023Cancer Management and Research8 citations Open access
Semantic Scholar
Malignant ectomesenchymoma in children: The European pediatric Soft tissue sarcoma Study Group experience
G. M. Milano, D. Orbach, M. Casanova, P. Berlanga +8 more
2022Pediatric Blood & Cancer8 citations Open access
Semantic Scholar
Abstract CT088: Phase I/II study of the PARP inhibitor olaparib in combination with irinotecan in children with advanced malignancies: arm D of the AcSé-ESMART trial
S. Gatz, P. Berlanga, Baptiste Archambaud, Y. Bouchoucha +22 more
2023Cancer Research7 citations
Semantic Scholar
Intra‐abdominal desmoplastic small round cell tumor: The European pediatric Soft tissue sarcoma Study Group (EpSSG) experience
P. Berlanga, D. Orbach, R. Schoot, M. Casanova +13 more
2023Pediatric Blood & Cancer7 citations Open access
Semantic Scholar
Securing access to innovative anticancer therapies for children, adolescents, and young adults outside clinical trials: The SACHA study of the French Society of Pediatric Oncology (SFCE).
P. Berlanga, L. A. Ndounga-Diakou, N. Corradini, S. Ducassou +10 more
2022Journal of Clinical Oncology7 citations
Semantic Scholar
Paediatric Strategy Forum for medicinal product development of agents targeting GD2 ganglioside in children and adolescents with cancer.
S. Dubois, Lucas Moreno, R. Bagatell, Nai-Kong V. Cheung +32 more
2025European Journal of Cancer6 citations Open access
Semantic Scholar
Adolescent‐ and adult‐onset neuroblastic tumor: A retrospective multicenter observational study of patients diagnosed in France between 2000 and 2020
Orlane Magnier, I. Schiff, J. Cristante, O. Chabre +22 more
2024Pediatric Blood & Cancer6 citations Open access
Semantic Scholar
Oral vinorelbine in young patients with desmoid-type fibromatosis
L. Kornreich, D. Orbach, Nayla Nicolas, H. Brisse +7 more
2023Tumori6 citations
Semantic Scholar
Neurotrophic tropomyosin receptor kinase (NTRK) fusion positive tumors: a historical cohort analysis
L. Lemelle, D. Guillemot, A. Hermann, A. Gauthier +18 more
2023Expert Review of Anticancer Therapy6 citations
Semantic Scholar
Epithelioid hemangioendothelioma in children: The European Pediatric Soft Tissue Sarcoma Study Group experience
D. Orbach, M. V. van Noesel, B. Brennan, N. Corradini +10 more
2022Pediatric Blood & Cancer6 citations Open access
Semantic Scholar
Phase 1/2 study of weekly nab-paclitaxel (nab-P) in pediatric patients (pts) with recurrent/refractory solid tumors (STs): Dose-finding and pharmacokinetics (PK).
L. Moreno, M. Casanova, J. Chisholm, P. Berlanga +16 more
20165 citations
Semantic Scholar
Chemo‐Immunotherapy Rescue for High‐Risk Neuroblastoma Patients With Progressive Disease Before High‐Dose Chemotherapy: Real‐World Data From the SACHA‐France Study
C. Pasqualini, Stéphanie Proust, G. Schleiermacher, M. Gambart +9 more
2025Pediatric Blood & Cancer4 citations Open access
Semantic Scholar
Can pediatric and adolescent patients with recurrent tumors benefit from a precision medicine program? The European MAPPYACTS experience.
P. Berlanga, G. Pierron, L. Lacroix, Tiphaine Adam de Beaumais +13 more
2019Journal of Clinical Oncology4 citations
Semantic Scholar
Abstract CT081: Pediatric precision medicine program in recurrent tumors: Results of the first 500 patients included in the European MAPPYACTS molecular profiling trial
P. Berlanga, G. Schleiermacher, L. Lacroix, G. Pierron +14 more
2019Clinical Trials4 citations
Semantic Scholar
[Recurrent or refractory Osteosarcoma and Ewing sarcoma-French guidelines from the FSG/NETSARC and GroupOs groups].
Mehdi Brahmi, M. Toulmonde, Sarah Winter, S. de Percin +10 more
2025Bulletin du Cancer3 citations
Semantic Scholar
Phase Ib study of the combination of regorafenib with conventional chemotherapy in patients with newly diagnosed multi-metastatic Ewing sarcoma: The Rego-Inter-Ewing-1 study.
P. Berlanga, D. Chaltiel, C. Lervat, N. Corradini +16 more
2025Journal of Clinical Oncology3 citations Open access
Semantic Scholar
Therapy and Outcomes of Patients with Relapsed Nonmetastatic Rhabdomyosarcoma: A Report from the French Society of Pediatric Oncology Malignant Mesenchymal Tumor Committee
F. Sevrin, E. Bogart, D. Orbach, M. le Deley +12 more
2024Cancer Medicine3 citations Open access
Semantic Scholar
LEIOMYOSARCOMA AND LIPOSARCOMA IN YOUNG PATIENTS: THE NATIONAL NETSARC+ NETWORK EXPERIENCE
Anne-Laure Genevois, M. Carton, M. Jean-Denis, J. Cyrta +26 more
2023EJC Paediatric Oncology3 citations Open access
Semantic Scholar
Phase I/II study of the PARP inhibitor olaparib and irinotecan in children and young adults with recurrent/refractory malignancies: Arm D of the AcSé-ESMART trial.
S. Gatz, P. Berlanga, G. Le Teuff, Ivan Valiev +35 more
2026Clinical Cancer Research2 citations Open access
Semantic Scholar
Factors associated with survival following relapse of high-risk neuroblastoma: A study from the International Neuroblastoma Risk Group (INRG) Data Commons.
Daniel A. Morgenstern, P. Kao, Lucas Moreno, J. Staunton +10 more
2025Journal of Clinical Oncology2 citations
Semantic Scholar
Interest of a sequential multimodal approach for the treatment of newly diagnosed patients with multimetastatic Ewing sarcoma: results of the French prospective CombinaiR3 phase II trial
V. Laurence, N. Jehanno, S. Dureau, Lieke Mous +28 more
2025British Journal of Cancer2 citations Open access
Semantic Scholar
Stakeholder Perspectives on Randomized Clinical Trials for Children With Poor-Prognosis Cancers.
N. Bird, Nicole Scobie, P. Berlanga, P. Blanc +22 more
2024JAMA Network Open2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Corradini×17
Invite
N. Corradini — researcher profile on SciRah
M. Casanova×16
Invite
M. Casanova — researcher profile on SciRah
B. Geoerger×13
Invite
B. Geoerger — researcher profile on SciRah
D. Orbach×12
Invite
D. Orbach — researcher profile on SciRah

×10

Invite

G. Vassal — researcher profile on SciRah

G. Schleiermacher×10

Invite

G. Schleiermacher — researcher profile on SciRah

A. Defachelles×10

Invite

A. Defachelles — researcher profile on SciRah

Invite

G. Pierron — researcher profile on SciRah

Invite

S. Abbou — researcher profile on SciRah

Invite

A. Ferrari — researcher profile on SciRah

Invite

R. Alaggio — researcher profile on SciRah

Invite

S. Gatz — researcher profile on SciRah